In other words, if AAT deficiency had not been fortuitously identified in 1963, it is unlikely that GWAS or exome-wide studies would have identified SERPINA1 variants (causing AAT deficiency) as a significant risk/associative factor for COPD. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.